ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992